BSE - Delayed Quote INR

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)

13.79
+0.27
+(2.00%)
At close: June 6 at 3:15:00 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Dakshesh Rameshchandra Shah Chairman & MD 5.04M -- 1972
Ms. Arpita Kabra Company Secretary & Compliance Officer -- -- 1993
Ms. Payalben Sujay Mehta Executive Director 138k -- 1980
Mr. Dhruvin Daksheshbhai Shah Additional Executive Director -- -- 1996
Ms. Sanskruti Jayeshbhai Patel Additional Executive Director -- -- 1996
Ms. Anar Jayesh Patel CFO & Whole Time Director -- -- 1970

Shukra Pharmaceuticals Limited

Veer House
3rd Floor Opp. WIAA Motor Training School Judges Bunglow Road, Bodakdev
Ahmedabad, 380054
India
91 79 4800 0430 https://www.shukrapharmaceuticals.com
Sector: 
Healthcare

Description

Shukra Pharmaceuticals Limited develops, manufactures, markets, and exports various drugs and dosage forms in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin. The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016. Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.

Corporate Governance

Shukra Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 29, 2025 at 10:59 AM UTC

Shukra Pharmaceuticals Limited Earnings Date

Recent Events

September 23, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers